SomaLogic (SLGC) has a profit margin of -159.54%, below the Healthcare sector average of 15.29%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
SomaLogic (SLGC) currently reports a profit margin of -159.54% as of September 2023. That is below the Healthcare sector average of 15.29%. Use the charts on this page to explore SomaLogic's profit margin history and peer comparisons.
SomaLogic's profit margin of -159.54% is lower than the Healthcare sector average of 15.29%. That is roughly 1143.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but SomaLogic's current -159.54% should be judged against Healthcare norms (sector average: 15.29%) and against SLGC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -159.54%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.29%. From there, open related valuation or income-statement pages for SomaLogic, and consider following SLGC for alerts when major investors trade the stock.
SomaLogic is classified in the Healthcare sector. On profit margin, it currently shows -159.54% versus a sector average near 15.29%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SLGC with unrelated industries.